FULGENT GENETICS, INC. Cost of Revenue
FULGENT GENETICS, INC. (FLGT) reported Cost of Revenue of $59.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-07-30
- FULGENT GENETICS, INC. cost of revenue for the quarter ending 2026-06-30 was $59.71M, a 26.06% increase year-over-year.
- FULGENT GENETICS, INC. cost of revenue for the quarter ending 2026-03-31 was $49.65M, a 10.04% increase year-over-year.
- FULGENT GENETICS, INC. cost of revenue for the quarter ending 2025-12-31 was $50.75M, a 14.40% increase year-over-year.
- FULGENT GENETICS, INC. cost of revenue for the quarter ending 2025-09-30 was $48.56M, a 7.97% increase year-over-year.
- FULGENT GENETICS, INC. cost of revenue for fiscal 2025 was $191.80M, a 8.82% increase from fiscal 2024.
- FULGENT GENETICS, INC. cost of revenue for fiscal 2024 was $176.25M, a 4.60% decline from fiscal 2023.
- FULGENT GENETICS, INC. cost of revenue for fiscal 2023 was $184.76M, a 26.70% decline from fiscal 2022.
- FULGENT GENETICS, INC. cost of revenue for fiscal 2022 was $252.07M, a 16.95% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $59.71M 10-Q · filed 2026-07-30 | $109.36M 10-Q · filed 2026-07-30 | $160.11M derived: sum of 3 quarters · filed 2026-07-30 | $208.67M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $49.65M 10-Q · filed 2026-05-01 | $100.40M derived: sum of 2 quarters · filed 2026-05-01 | $148.96M derived: sum of 3 quarters · filed 2026-05-01 | $196.33M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $50.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $99.31M derived: sum of 2 quarters · filed 2026-02-27 | $146.68M derived: sum of 3 quarters · filed 2026-07-30 | $191.80M 10-K · filed 2026-02-27 |
| 2025-09-30 | $48.56M 10-Q · filed 2025-11-07 | $95.92M derived: sum of 2 quarters · filed 2026-07-30 | $141.04M 10-Q · filed 2025-11-07 | $185.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $47.37M 10-Q · filed 2026-07-30 | $92.48M 10-Q · filed 2026-07-30 | $136.85M derived: sum of 3 quarters · filed 2026-07-30 | $181.82M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $45.12M 10-Q · filed 2026-05-01 | $89.48M derived: sum of 2 quarters · filed 2026-05-01 | $134.45M derived: sum of 3 quarters · filed 2026-05-01 | $178.99M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $44.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $89.34M derived: sum of 2 quarters · filed 2026-02-27 | $133.87M derived: sum of 3 quarters · filed 2026-02-27 | $176.25M 10-K · filed 2026-02-27 |
| 2024-09-30 | $44.97M 10-Q · filed 2025-11-07 | $89.51M derived: sum of 2 quarters · filed 2025-11-07 | $131.89M 10-Q · filed 2025-11-07 | $177.17M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $44.54M 10-Q · filed 2025-08-01 | $86.92M 10-Q · filed 2025-08-01 | $132.19M derived: sum of 3 quarters · filed 2026-02-27 | $177.04M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $42.38M 10-Q · filed 2025-05-02 | $87.66M derived: sum of 2 quarters · filed 2026-02-27 | $132.50M derived: sum of 3 quarters · filed 2026-02-27 | $179.78M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $45.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $90.12M derived: sum of 2 quarters · filed 2026-02-27 | $137.40M derived: sum of 3 quarters · filed 2026-02-27 | $184.76M 10-K · filed 2026-02-27 |
| 2023-09-30 | $44.84M 10-Q · filed 2024-11-08 | $92.12M derived: sum of 2 quarters · filed 2024-11-08 | $139.48M 10-Q · filed 2024-11-08 | $194.20M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $47.28M 10-Q · filed 2024-08-02 | $94.64M 10-Q · filed 2024-08-02 | $149.35M derived: sum of 3 quarters · filed 2024-08-02 | $208.91M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $47.36M 10-Q · filed 2024-05-03 | $102.07M derived: sum of 2 quarters · filed 2024-05-03 | $161.63M derived: sum of 3 quarters · filed 2024-05-03 | $221.70M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $54.72M 10-K · filed 2023-02-28 | $114.28M derived: sum of 2 quarters · filed 2023-11-03 | $174.34M derived: sum of 3 quarters · filed 2023-11-03 | $252.07M 10-K · filed 2025-02-28 |
| 2022-09-30 | $59.56M 10-Q · filed 2023-11-03 | $119.63M derived: sum of 2 quarters · filed 2023-11-03 | $197.35M 10-Q · filed 2023-11-03 | $259.48M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $60.06M 10-Q · filed 2023-08-04 | $137.79M 10-Q · filed 2023-08-04 | $199.92M derived: sum of 3 quarters · filed 2023-08-04 | $243.39M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $77.72M 10-Q · filed 2023-05-05 | $139.86M derived: sum of 2 quarters · filed 2023-05-05 | $183.32M derived: sum of 3 quarters · filed 2023-05-05 | $219.18M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $62.13M 10-K · filed 2023-02-28 | $105.60M derived: sum of 2 quarters · filed 2023-02-28 | $141.46M derived: sum of 3 quarters · filed 2023-02-28 | $215.53M 10-K · filed 2024-02-28 |
| 2021-09-30 | $43.47M 10-K · filed 2023-02-28 | $79.32M derived: sum of 2 quarters · filed 2023-02-28 | $153.40M 10-Q · filed 2022-11-07 | $205.17M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $35.86M 10-K · filed 2023-02-28 | $109.93M 10-Q · filed 2022-08-04 | $161.71M derived: sum of 3 quarters · filed 2023-02-28 | $187.97M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $74.08M 10-K · filed 2023-02-28 | $125.85M derived: sum of 2 quarters · filed 2023-02-28 | $152.11M derived: sum of 3 quarters · filed 2023-02-28 | $159.82M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $51.77M 10-K · filed 2022-02-28 | $78.03M derived: sum of 2 quarters · filed 2022-02-28 | $85.75M derived: sum of 3 quarters · filed 2022-02-28 | $89.81M 10-K · filed 2023-02-28 |
| 2020-09-30 | $26.26M 10-K · filed 2022-02-28 | $33.98M derived: sum of 2 quarters · filed 2022-02-28 | $38.03M 10-Q · filed 2021-11-09 | $41.67M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $7.72M 10-K · filed 2022-02-28 | $11.77M 10-Q · filed 2021-08-10 | $15.41M derived: sum of 3 quarters · filed 2022-02-28 | $19.29M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $4.06M 10-K · filed 2022-02-28 | $7.69M derived: sum of 2 quarters · filed 2022-02-28 | $11.58M derived: sum of 3 quarters · filed 2022-02-28 | $15.20M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $3.63M 10-K · filed 2021-03-08 | $7.52M derived: sum of 2 quarters · filed 2021-03-08 | $11.14M derived: sum of 3 quarters · filed 2021-03-08 | $14.11M 10-K · filed 2022-02-28 |
| 2019-09-30 | $3.88M 10-K · filed 2021-03-08 | $7.50M derived: sum of 2 quarters · filed 2021-03-08 | $10.47M 10-Q · filed 2020-11-09 | $13.24M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $3.62M 10-K · filed 2021-03-08 | $6.59M 10-Q · filed 2020-08-05 | $9.36M derived: sum of 3 quarters · filed 2021-03-08 | $11.97M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $2.97M 10-K · filed 2021-03-08 | $5.74M derived: sum of 2 quarters · filed 2021-03-08 | $8.35M derived: sum of 3 quarters · filed 2021-03-08 | $10.89M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $2.77M 10-K · filed 2020-03-13 | $5.38M derived: sum of 2 quarters · filed 2020-03-13 | $7.92M derived: sum of 3 quarters · filed 2020-03-13 | $10.70M 10-K · filed 2020-03-13 |
| 2018-09-30 | $2.61M 10-K · filed 2020-03-13 | $5.16M derived: sum of 2 quarters · filed 2020-03-13 | $7.93M 10-Q · filed 2019-11-08 | $10.47M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $2.54M 10-K · filed 2020-03-13 | $5.32M 10-Q · filed 2019-08-12 | $7.86M derived: sum of 3 quarters · filed 2020-03-13 | $10.13M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $2.77M 10-K · filed 2020-03-13 | $5.32M derived: sum of 2 quarters · filed 2020-03-13 | $7.58M derived: sum of 3 quarters · filed 2020-03-13 | $9.46M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $2.54M 10-K · filed 2019-03-22 | $4.81M derived: sum of 2 quarters · filed 2019-03-22 | $6.69M derived: sum of 3 quarters · filed 2019-03-22 | $8.55M 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.27M 10-K · filed 2019-03-22 | $4.15M derived: sum of 2 quarters · filed 2019-03-22 | $6.01M 10-Q · filed 2018-11-09 | $7.87M derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-06-30 | $1.88M 10-K · filed 2019-03-22 | $3.74M 10-Q · filed 2018-08-13 | $5.60M derived: sum of 3 quarters · filed 2019-03-22 | $7.74M derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-03-31 | $1.86M 10-K · filed 2019-03-22 | $3.72M derived: sum of 2 quarters · filed 2019-03-22 | $5.87M derived: sum of 3 quarters · filed 2019-03-22 | $7.28M derived: sum of 4 quarters · filed 2019-03-22 |
| 2016-12-31 | $1.86M 10-K · filed 2018-03-20 | $4.01M derived: sum of 2 quarters · filed 2018-03-20 | $5.42M derived: sum of 3 quarters · filed 2018-03-20 | $6.72M 10-K · filed 2018-03-20 |
| 2016-09-30 | $2.14M 10-K · filed 2018-03-20 | $3.55M derived: sum of 2 quarters · filed 2018-03-20 | $4.86M 10-Q · filed 2017-11-13 | $7.58M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | $1.41M 10-K · filed 2018-03-20 | $2.71M 10-Q · filed 2017-08-14 | $5.44M derived: sum of 3 quarters · filed 2018-03-20 | $6.36M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-03-31 | $1.30M 10-K · filed 2018-03-20 | $4.03M derived: sum of 2 quarters · filed 2018-03-20 | $4.95M derived: sum of 3 quarters · filed 2018-03-20 | $5.72M derived: sum of 4 quarters · filed 2018-03-20 |
| 2015-12-31 | $2.73M 10-K · filed 2017-03-17 | $3.64M derived: sum of 2 quarters · filed 2017-03-17 | $4.42M derived: sum of 3 quarters · filed 2017-03-17 | $5.07M 10-K · filed 2017-03-17 |
| 2015-09-30 | $918.00K 10-K · filed 2017-03-17 | $1.69M derived: sum of 2 quarters · filed 2017-03-17 | $2.34M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $772.00K 10-K · filed 2017-03-17 | $1.43M derived: sum of 2 quarters · filed 2017-03-17 | ||
| 2015-03-31 | $653.00K 10-K · filed 2017-03-17 | |||
| 2014-12-31 | $936.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |